FDA and European Union expand Mutual Recognition Agreement to include animal drugs
The joint decision to expand the MRA's Sectoral Annex for Pharmaceutical Good Manufacturing Practices is a step toward strengthening use of each other’s animal drug inspection expertise and resources
Drug for acute onset of canine pancreatitis is launched on the US market
Conditionally approved by the FDA, fuzapladib sodium for injection is a leukocyte function-associated antigen-1 activation inhibitor.
FDA approves first monoclonal antibody for managing OA pain in dogs
Zoetis’ bedinvetmab injection is a prescription solution targeting canine nerve growth factor.
FDA conditionally approves first drug for anemia in cats
The first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats
New broad-spectrum parasite protection for cats receives FDA approval
The NexGard COMBO topical solution from Boehringer Ingelheim helps prevent tapeworms and other intestinal parasites as well as fleas, ticks, and heartworms.